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MOLECULAR MECHANISMS OF BONE RESORPTION IN PERIODONTITIS 
 
BACKGROUND AND AIM 
Periodontal diseases are a group of highly prevalent oral infections that cause the 
inflammatory destruction of the tooth-supporting (periodontal) tissues. The 
inflammation can be restricted to the gingival tissue, clinically manifesting as 
gingivitis, or expand deeper to affect the tooth-supporting alveolar bone and 
periodontal ligament, manifesting as periodontitis. If left untreated, periodontitis may 
eventually lead to tooth loss. Etiologically, periodontal diseases are caused by 
indigenous oral bacteria, which attach on the tooth surface and grow as polymicrobial 
“biofilm” communities. Within biofilms, individual bacteria benefit from each other and 
develop strategies that prolong their survival in the host [1]. Porphyromonas 
gingivalis is a Gram negative anaerobe, typically present in subgingival biofilms from 
sites with periodontitis, particularly the chronic form. Due to its virulence factors, such 
as the cysteine proteinases (gingipains), P. gingivalis can deregulate the innate 
immune responses in favour of its survival within the host environment [2]. The host 
elicits a local inflammatory response against biofilms or their released bacterial 
products, which is meant to be protective. However, if this response becomes 
excessive, it could lead to damage of the supporting alveolar bone, resulting in 
periodontitis. 
Bone resorption is regulated by the interplay of Receptor Activator of NF-kB 
Ligand (RANKL) and osteoprotegerin (OPG), two molecules belonging to the tumor 
necrosis factor ligand and receptor families, respectively [3]. RANKL, produced by 
various cells, stimulates its cognate RANK receptor on pre-osteoclasts and 
subsequently their differentiation into multi-nucleated osteoclasts, which will resorb 
bone. On the contrary, OPG inhibits the action of RANKL by binding to it, thus 
preventing osteoclast differentiation and bone resorption. A local increase of the 
RANKL/OPG ratio is observed at sites exhibiting enhanced bone resorption [4]. 
Since the RANKL-OPG system is crucial for controlling bone resorption, 
imbalances in its expression may cause a switch from a physiological to a 
pathological state at different sites of the human skeleton. Hence, the aim of these 
studies was to evaluate how this system could be involved in the pathogenesis of 
human periodontitis, by investigating clinical and mechanistic aspects of its 
regulation. 
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METHODS 
This work includes a clinical and an in vitro component, both ultimately studying 
RANKL and OPG gene expression in the two different experimental platforms. In the 
clinical part (Paper 1), gingival biopsies were obtained from periodontally healthy and 
diseased sites. The levels or RANKL and OPG mRNA expression in these samples 
was assessed by quantitative real-time Polymerase Chain Reaction (qPCR). The in 
vitro experimentations focused on the potential biological mechanisms of RANKL and 
OPG regulation. In two of the studies (Paper 2 and Paper 3), P. gingivalis products 
were added to host cell cultures, including gingival fibroblasts (GF), periodontal 
ligament cells and T-cells. RANKL and OPG mRNA expression in these P. gingivalis-
challenged cells was investigated by qPCR. The relative effects of P. gingivalis 
gingipains, were evaluated by using genetically modified strains lacking the capacity 
to produce these virulence factors. The latest study (Paper 4) investigated 
accordingly the effects of polymicrobial biofilms on the RANKL-OPG system. GF 
cultures were challenged with secreted products of an in vitro supragingival biofilm 
model consisting of 6 species, or a subgingival biofilm model of 10 species, including 
P. gingivalis. The RANKL and OPG mRNA expressions were investigated by qPCR.  
FINDINGS AND DISCUSSION 
The relevance of the RANKL-OPG system in human periodontitis was confirmed in 
the cross-sectional clinical study. RANKL was not expressed in healthy gingival 
tissues, but OPG was constantly expressed denoting its protective role from bone 
resorption. This pattern was similar in gingivitis, indicating that despite the on-going 
inflammation, the bone resorption mechanism is still not activated in this form of the 
disease. However, a limited number of sites with gingivitis also expressed RANKL, 
which could represent sites of on-going switch to periodontitis. To this extent, RANKL 
expression levels were increased in periodontitis, whereas OPG levels were 
significantly lower than in health or gingivitis. These differential expressions reflected 
an increased RANKL/OPG ratio in periodontitis, compared to health or gingivitis, 
confirming the association of this measure to enhanced bone destruction. 
The mechanisms of RANKL-OPG regulation were investigated in more depth 
using in vitro experimental systems. The major periodontal pathogen P. gingivalis 
induced RANKL and partly reduced OPG expression in GF and PDL cells. This 
resulted in an increased RANKL/OPG ratio, which denotes an enhanced capacity by 
the cells to stimulate bone resorption. The P. gingivalis virulence factor responsible 
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for the induction of RANKL is potentially a protein which could be functionally 
associated with the gingipains, but a non-proteinaceous component is likely to be 
responsible for OPG reduction. P. gingivalis also induced RANKL in T-cells, which, 
however, were not able to produce OPG. These in vitro observations are in 
agreement the potential of P. gingivalis to act as a periodontal pathogen [2], and 
match the clinical findings, where the switch from health to periodontitis is associated 
with increased RANKL and decreased OPG expression.  
As periodontitis is an infection of polymicrobial nature, it is rational to consider 
the effects of multi-species biofilms, in the regulation of the RANKL-OPG system. In 
the present experimental system, an in vitro supragingival and a subgingival biofilm 
model both caused enhancement of the RANKL/OPG expression ratio in GF, albeit 
the latter was considerably more potent in this respect. These findings provide a 
molecular proof of the clinical concept that subgingival biofilms are of higher virulence 
for the development of periodontitis [5].  
CONCLUSION AND SIGNIFICANCE 
The molecular signature of periodontitis is characterised by increased RANKL and 
decreased OPG expression, resulting in an increased RANKL/OPG ratio, as in other 
bone destructive diseases, like rheumatoid arthritis or osteoporosis [4]. Putative 
periodontal pathogens associated with subgingival biofilms, such as P. gingivalis, are 
likely to regulate this system in favour of bone destruction, which is a hallmark of 
periodontitis. Understanding the role and regulation of the RANKL-OPG system in 
periodontitis may provide insights for development of molecular diagnostic or 
therapeutic targets for the disease, for instance by blocking RANKL [6], or by 
eradicating the stimulating microbial factors. 
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